CELL AND GENE THERAPY INSIGHTS

Strategies for Scale-up & Scale-out

December 2018
Strategies for Scale-up & Scale-out
Download PDF

Editorial

Critical considerations for allogeneic cell therapy scale up

Critical considerations for allogeneic cell therapy scale up

Sharon Grimster
18 December 2018
Read

Research Article

Scale-up of a perfusion-based dendritic cell generation process

Scale-up of a perfusion-based dendritic cell generation process

A Kozbial, H Weinstein, S K Murthy et al.
18 December 2018
Read

Expert Insight

The long road to affordability: a cost of goods analysis for an autologous CAR-T process

The long road to affordability: a cost of goods analysis for an autologous CAR-T process

Katy Spink, Andrew Steinsapir
18 December 2018
Read
Back to the future: where are we taking lentiviral vector manufacturing?

Back to the future: where are we taking lentiviral vector manufacturing?

Hanna P Lesch
18 December 2018
Read
Translating cell and gene therapies to the clinic

Translating cell and gene therapies to the clinic

H Dave, D Saunders, N Zhang et al.
18 December 2018
Read

Innovator Insight

Commercial Lessons for Clinical Success

Commercial Lessons for Clinical Success

Simon Ellison, Heidi Hagen, Christophe Suchet
19 December 2018
Read

Interview

Biopharma scale-up lessons to learn for cell & gene therapy

Biopharma scale-up lessons to learn for cell & gene therapy

Nik Willoughby
8 January 2019
Read
Towards commercial allogeneic cell therapy manufacturing

Towards commercial allogeneic cell therapy manufacturing

Maria Del Pilar Redondo
18 December 2018
Read
Autologous T cell immunotherapy scale out manufacturing models – the biotech perspective

Autologous T cell immunotherapy scale out manufacturing models – the biotech perspective

Nina Kotsopoulou
18 December 2018
Read